Skip to main content
    V

    Viking Therapeutics Inc (VKTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $26.88
    +0.08 (+0.30%)

    Market Cap: $3.73B

    Last updated: Nov 17, 2026 at 4:43 PM ET

    Viking Therapeutics Inc (VKTX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Viking Therapeutics (VKTX) has a latest price of $26.88 on Nov 17, 2026, 37.6% below its 52-week high of $43.10. Its price fell 31.3% over the past 12 months. The month-end price rose 2,449.5% over the 10 years through Oct 2026, a compound annual rate of 38.2%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $82.00 in Mar 2024 and its lowest $1.04 in Aug 2017, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart VKTX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for VKTX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 25.3%, and over 6 months it fell 5.4%. The month-end price rose 178.1% over the 3 years through Oct 2026, a compound annual rate of 40.6%.

    PeriodChange
    1 month+7.3%
    3 months-25.3%
    6 months-5.4%
    12 months-31.3%
    12 months, with dividends-31.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+178.1%+40.6%
    5 years+368.7%+36.2%
    10 years+2,449.5%+38.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 241.2%, and its weakest was 2020, when it fell 29.8%.

    YearCloseChange
    2026 through Oct 2026$27.28-22.5%
    2025$35.18-12.6%
    2024$40.24+116.2%
    2023$18.61+98.0%
    2022$9.40+104.3%
    2021$4.60-18.3%
    2020$5.63-29.8%
    2019$8.02+4.8%
    2018$7.65+88.4%
    2017$4.06+241.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 7.4% below its 50-day average of $29.03 and 16.4% below its 200-day average of $32.14.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$26.88
    52-week high$43.10-37.6%
    52-week low$23.82+12.8%
    50-day average$29.03-7.4%
    200-day average$32.14-16.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 78.9%.

    MeasureValue
    1-year beta1.36
    Largest fall, 1 year-42.5%
    Largest fall, 3 years-78.9%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About VKTX

    What is VKTX's 1-year price change?

    Viking Therapeutics's price fell 31.3% over the past 12 months. With dividends included, the 12-month total return was -31.3%.

    What is VKTX's 5-year price change?

    Viking Therapeutics's month-end price rose 368.7% over the 5 years through Oct 2026, a compound annual rate of 36.2%. These figures leave out dividends.

    What is VKTX's 52-week high and low?

    Viking Therapeutics's 52-week high is $43.10 and its 52-week low is $23.82. Its latest price of $26.88 on Nov 17, 2026 is 37.6% below the high.

    What is VKTX's beta?

    Viking Therapeutics's 1-year beta against the S&P 500 is 1.36, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 42.5%.

    Is the VKTX chart free?

    Yes. Advanced Charting for VKTX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.